Other factors like competition from other amino acids, reduced uptake by cationic amino acid transporters (CATs), and elevated arginase activity—common in conditions such as hypertension and diabetes—can limit L-arginine availability to eNOS, diverting it away from NO production (McDonald et al., 1997a; McDonald et al., 1997b). Here, NOS3 is linked to diabetes mellitus.